Clinical trial
A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ Device (The ShortCut™ CAS).
NCT06211296 is registered in ClinicalTrials.gov with Pi-cardia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ Device (The ShortCut™ CAS).
- Lead sponsor
- Pi-cardia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 3, 2024
- Completion date
- May 12, 2025
- Enrollment
- 8 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, coronary; obstruction, valve-in-valve procedures